Brief report Tempol, a novel antioxidant, inhibits both activated T cell and antigen presenting cell derived cytokines in-vitro from COVID-19 patients

von Mathi, Kavita
Veröffentlicht in: Clinical immunology (Orlando, Fla.) (2021)